Outlook Therapeutics, Inc. (OTLK) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Outlook Therapeutics, Inc. (OTLK) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

OTLK Income Statement

Outlook Therapeutics, Inc. (OTLK) annual income statement — 12-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	9K	127.44K	-1.21M	-91.79K	1.51M	0	0	170.12K	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-99.4%	-	-	-153.95%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	17K	149.33K	29.63K	916.51K	439.81K	0	28.8K	85.06K	28.67K	28.2K	28.2K	11.22K	0	0	0	0	0	0	0	0
COGS % of Revenue	188.89%	117.18%	-2.45%	-998.52%	29.22%	-	-	50%	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-8K	-21.89K	-1.24M	-1.01M	1.07M	0	-28.8K	85.06K	-28.67K	-28.2K	-28.2K	-11.22K	0	0	0	0	0	0	0	0
Gross Margin %	-88.89%	-17.18%	102.45%	1098.52%	70.78%	-	-	50%	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-100.75%	-	-4196.58%	-1285.37%	3816.19%	100%	-2.15%	858.33%	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	10.8M	14.01M	12.25M	16.31M	16.81M	12.39M	21.58M	22.88M	19.56M	18.94M	10.32M	12.46M	18.14M	6.84M	15.69M	13.99M	17.02M	18.91M	13.15M	13.44M
OpEx % of Revenue	120022.22%	10989.65%	-1013.92%	-17765.37%	1116.98%	-	-	13447.25%	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	7.55M	9.5M	8.61M	10.33M	9.68M	7.98M	11.95M	10.35M	8.36M	5.43M	5.79M	7.51M	7.04M	6.29M	5.83M	5M	5.78M	6.69M	3.28M	3.5M
SG&A % of Revenue	83900%	7458.14%	-713.02%	-11251.64%	643.02%	-	-	6086.15%	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	3.25M	4.5M	3.63M	5.98M	7.13M	4.41M	9.66M	12.52M	11.2M	13.51M	4.53M	4.94M	11.1M	544.95K	9.86M	8.99M	11.25M	12.22M	9.87M	9.94M
R&D % of Revenue	36122.22%	3531.51%	-300.9%	-6513.74%	473.97%	-	-	7361.1%	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	-29K	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-10.81M	-14.03M	-13.48M	-17.31M	-15.75M	-12.39M	-21.61M	-22.88M	-19.56M	-18.94M	-10.32M	-12.46M	-18.14M	-6.84M	-15.69M	-13.99M	-17.02M	-18.91M	-13.15M	-13.44M
Operating Margin %	-120111.11%	-11006.82%	1116.38%	18863.9%	-1046.2%	-	-	-13447.25%	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	31.36%	-13.2%	37.59%	24.31%	19.5%	34.57%	-109.31%	-83.62%	-7.84%	-176.98%	34.2%	10.93%	-6.56%	63.84%	-19.3%	-4.11%	-48.36%	-49.78%	7.34%	-34.17%
EBITDA	-10.87M	-14M	-13.45M	-17.28M	-15.72M	-12.36M	-21.58M	-22.85M	-19.53M	-18.91M	-10.29M	-12.45M	-18.13M	-6.83M	-15.68M	-13.94M	-16.97M	-18.86M	-13.1M	-13.39M
EBITDA Margin %	-120783.23%	-10982.96%	1113.89%	18831.5%	-1044.25%	-	-	-13430.32%	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	30.85%	-13.22%	37.65%	24.35%	19.53%	34.63%	-109.6%	-83.55%	-7.75%	-177.01%	34.33%	10.68%	-6.82%	63.8%	-19.68%	-4.12%	-48.53%	-50.36%	7.16%	-34.74%
D&A (Non-Cash Add-back)	-60.49K	30.42K	30.07K	29.74K	29.41K	29.1K	28.8K	28.8K	28.67K	28.2K	28.2K	11.22K	11.19K	11K	10.78K	51.47K	51.27K	51.09K	50.87K	50.67K
EBIT	-20.28M	-14.03M	-13.48M	-14.58M	-20.1M	-12.39M	-21.61M	5.69M	44.41M	-18.94M	-10.32M	-16.75M	-20.68M	-6.84M	-15.69M	-13.98M	-17.02M	-18.91M	-14.11M	-13.13M
Net Interest Income	0	3	0	-264.16K	-49.35K	-18.5K	48.88K	239.95K	404.59K	-3.08M	188.68K	305.81K	395.23K	187.79K	-2.45M	-361K	-357K	-418K	-352K	-269K
Interest Income	0	3	0	0	0	0	48.88K	239.95K	404.59K	0	188.68K	305.81K	395.54K	187.79K	0	0	0	0	0	0
Interest Expense	0	0	0	264.16K	49.35K	18.5K	0	0	0	3.08M	0	0	303	0	2.45M	360.65K	356.95K	418.33K	351.53K	269.18K
Other Income/Expense	-9.47M	9.57M	-9.57M	2.47M	-4.4M	-33.96M	38.98M	28.57M	63.97M	-95.35M	-855K	-532K	-2.53M	186.44K	-2.97M	-357K	-516K	-793K	-1.31M	31.15K
Pretax Income	-20.28M	-4.45M	-23.06M	-14.85M	-20.15M	-46.35M	17.38M	5.69M	44.41M	-114.29M	-11.18M	-12.99M	-20.68M	-6.65M	-18.66M	-14.34M	-17.54M	-19.7M	-14.46M	-13.4M
Pretax Margin %	-225311.11%	-3494.28%	1909.05%	16175.93%	-1338.75%	-	-	3345.21%	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	41K	0	0	-1.55M	0	2.8K	0	0	0	2.8K	0	0	0	2.8K	0	800	0	2K	0	0
Effective Tax Rate %	-0.2%	0%	0%	10.47%	0%	-0.01%	0%	0%	0%	-0%	0%	0%	0%	-0.04%	0%	-0.01%	0%	-0.01%	0%	0%
Net Income	-20.32M	-4.45M	-23.06M	-13.29M	-20.15M	-46.36M	17.38M	5.69M	44.41M	-114.29M	-11.18M	-12.99M	-20.68M	-6.65M	-18.66M	-14.35M	-17.54M	-19.7M	-14.46M	-13.4M
Net Margin %	-225766.67%	-3494.28%	1909.05%	14482.19%	-1338.75%	-	-	3345.21%	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.83%	90.39%	-232.69%	-333.58%	-145.38%	59.44%	255.47%	143.81%	314.8%	-1617.6%	40.11%	9.44%	-17.87%	66.23%	-29.04%	-7.02%	-43.81%	-50.34%	-0.05%	-35.09%
Net Income (Continuing)	-20.32M	-4.45M	-23.06M	-13.29M	-20.15M	-46.36M	17.38M	5.69M	44.41M	-114.29M	-11.18M	-12.99M	-20.68M	-6.65M	-18.66M	-14.35M	-17.54M	-19.7M	-14.46M	-13.4M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.80	-0.17	-0.38	-0.52	-0.55	-1.50	0.72	0.31	-0.89	-8.01	-0.86	-1.00	-1.61	-0.52	-1.60	-1.35	-1.60	-1.80	-1.60	-1.59
EPS Growth %	-45.45%	88.67%	-152.78%	-267.74%	38.2%	81.27%	183.72%	131%	44.72%	-1440.38%	46.25%	25.93%	-0.63%	71.11%	0%	15.09%	-14.29%	0%	32.49%	27.4%
EPS (Basic)	-0.80	-0.05	-0.38	-0.38	-0.55	-1.50	0.72	0.31	1.91	-8.01	-0.86	-1.00	-1.61	-0.52	-1.60	-1.35	-1.60	-1.80	-1.60	-1.59
Diluted Shares Outstanding	25.48M	25.48M	25.48M	25.48M	36.96M	30.87M	24.23M	18.55M	25.48M	14.27M	13.01M	13.01M	12.84M	12.83M	11.37M	10.6M	11.03M	10.95M	9.41M	8.42M
Basic Shares Outstanding	25.48M	81.84M	60.2M	34.8M	36.96M	30.87M	24.23M	18.55M	23.28M	14.27M	13.01M	13.01M	12.84M	12.83M	11.37M	10.6M	11.03M	10.95M	9.41M	8.42M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-